small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (971)
  • Capabilities (90)
  • Experience (534)
  • Insights & News (6,856)
  • Other Results (131)

Professionals 971 results

Thomas M. Melsheimer
Thomas M. Melsheimer
Partner
  • Dallas
Email
+1 214-453-6401
vCard

Partner

  • Dallas
Steve D’Amore
Steve D’Amore
Partner
  • Chicago
Email
+1 312-558-5934
vCard

Partner

  • Chicago
James P.  Smith III
James P. Smith III
Partner
  • New York
Email
+1 212-294-4633
vCard

Partner

  • New York
View All Professionals

Capabilities 90 results

Practice Area

Litigation/Trials

Trial skills matter—even in a world where few disputes ever see the inside of a courtroom. Winston has built a reputation as a trial lawyers’ firm, featuring seasoned litigators who leverage extensive courtroom experience to meet our clients’ business and legal objectives. Our long history of taking cases to trial—and winning—provides our clients with tremendous settlement leverage with their adversaries, as well as a substantial likelihood of a favorable resolution if, and when, they go to trial....Read more

Industry

Insurance

Insurance plays an essential role in risk mitigation for financial services companies. As risks evolve, questions often arise concerning the scope of insurance coverage and the interpretation and application of policy provisions. Winston’s insurance lawyers provide companies with best-in-class advice, corporate and transactional counsel, and, if need be, litigation defense in high-stakes coverage disputes and class actions. We have achieved excellent outcomes for our clients in matters involving a wide variety of insurance policies and claims, including cybersecurity, travel, long-term care, and annuities, among others. Moreover, we have experience in emerging issues and industries, such as blockchain technology and artificial intelligence, both of which present insurers with a unique and complicated set of risks and opportunities....Read more

Industry

Artificial Intelligence (AI)

Experience 534 results

Experience

|

December 15, 2025

Winston & Strawn LLP represented Apogem in the closing of a single-asset continuation vehicle for Lion Beverages, LLC.

Winston & Strawn LLP represented Apogem in the closing of a single-asset continuation vehicle for Lion Beverages, LLC. The transaction, led by Apogem and including J.P. Morgan Asset Management, RCP Advisors, and Montana Capital Partners, raised over $150 million, with significant participation from Encore Consumer Capital. The meaningful GP commitment underscores both confidence in Lion and alignment with investors....Read more

Experience

|

November 26, 2025

Winston & Strawn Represented CFS Brands in its Acquisition of Cornerstone Foodservice Group

Winston represented CFS Brands, a portfolio company of TJC, in its acquisition of Cornerstone Foodservice Group, a global leader in foodservice equipment serving both front- and back-of-house applications through a portfolio of established, innovative brands. ...Read more

Experience

|

November 19, 2025

Blockfusion Enters into Business Combination with Blue Acquisition Corp.

Winston & Strawn LLP represents Blockfusion, the owner-operator of a strategically located, clean-energy-powered data center, in its announced business combination with Blue Acquisition Corp., a publicly traded special purpose acquisition company. The transaction attributes a pre-money equity value of approximately USD 450 million to Blockfusion and would result in Blockfusion becoming a publicly traded company upon listing....Read more
View All Experience

Insights & News 6,856 results

Seminar/CLE

|

January 20, 2026

2026 NYC SBIC Fund Conference

Winston & Strawn and RSM US LLP are co-hosting the annual NYC SBIC Fund Conference on Tuesday, January 20, 2026.General and limited partners, chief financial officers, and controllers of small business investment company (SBIC) funds are invited to a half-day seminar covering various topics related to SBIC fund operations, including:...Read more

Winston’s Environmental Law Update

|

December 23, 2025

|

3 Min Read

“Compliance First”: What Does EPA’s New Policy Mean for My Business?

On December 5, 2025, the U.S. Environmental Protection Agency (EPA) Office of Enforcement and Compliance Assurance (OECA) issued an internal policy memorandum[1]that sets a “compliance first” directive for EPA’s enforcement programs.

Competition Corner

|

December 23, 2025

|

4 Min Read

The Continuing Expansion of Algorithmic Software Laws – Best Practices for Companies in an Evolving Landscape

New York recently expanded its algorithmic pricing laws, now requiring retailers to disclose when prices are set with algorithmic software based on consumers’ personal data.The so-called practice of surveillance pricing entails adjusting prices charged for goods and services according to monitored personal data.

View All Insights & News

Other Results 131 results

Experienced Attorneys

Law Glossary

What Is the Patent Trial and Appeal Board?

The Patent Trial and Appeal Board (PTAB) is a tribunal within U.S. Patent and Trademark Office. The PTAB oversees trial proceedings, namely: inter partes review (IPR), post-grant review (PGR), covered business method (CBM) review, and derivation proceedings. The Board also hears appeals from adverse patentability decisions by patent examiners in original applications, reissues, and reexaminations. And, while phasing out since the passage of the America Invents Act (AIA) in 2011, the PTAB is also responsible for deciding interferences. The PTAB was previously referred to as the Board of Patent Appeals and Interferences and was renamed by the AIA....Read more

Law Glossary

What Exclusivity Periods Are Associated with Biosimilars?

An applicant may not submit an aBLA until four years after the reference product is licensed by the FDA. (See BPCIA § 351(k).) Further, any biosimilar licenses “may not be made effective” until 12 years after the reference product was licensed. (See BPCIA § 351(l).)...Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising